Desq Long
Sign in

Company

Cue Biopharma, Inc.

CUE · CIK 0001645460

SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code A) of 18,900 shares at $0 per share.

Reporting Person Garzone Pamela · Transaction Code A

Traded Jul 9, 2026 · Disclosed Aug 28, 2026FILED +50 DAYS

Source: SEC Form 4 · 0001974756-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code A) of 18,400 shares at $0 per share.

Reporting Person Sarraf Pasha · Transaction Code A

Traded Jul 9, 2026 · Disclosed Aug 28, 2026FILED +50 DAYS

Source: SEC Form 4 · 0002059447-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code M) of 18,196 shares at $0 per share.

Reporting Person Ray Sumita · Officer Title Chief Legal Compliance Officer · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001579629-26-000008 · filed 2026-08-17 · View filing →

SEC FORM 4
$69,988.71

Cue Biopharma, Inc. (CUE)

Sale of 2,383 shares at $29.37 per share.

Reporting Person Ray Sumita · Officer Title Chief Legal Compliance Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001579629-26-000008 · filed 2026-08-17 · View filing →

SEC FORM 4
$195,514.70

Cue Biopharma, Inc. (CUE)

Sale of 6,442 shares at $30.35 per share.

Reporting Person Ray Sumita · Officer Title Chief Legal Compliance Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001579629-26-000008 · filed 2026-08-17 · View filing →

SEC FORM 4
$124.52

Cue Biopharma, Inc. (CUE)

Sale of 4 shares at $31.13 per share.

Reporting Person Ray Sumita · Officer Title Chief Legal Compliance Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001579629-26-000008 · filed 2026-08-17 · View filing →

SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code M) of 13,647 shares at $0 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0002138368-26-000007 · filed 2026-08-17 · View filing →

SEC FORM 4
$44,613.03

Cue Biopharma, Inc. (CUE)

Sale of 1,519 shares at $29.37 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0002138368-26-000007 · filed 2026-08-17 · View filing →

SEC FORM 4
$124,617.10

Cue Biopharma, Inc. (CUE)

Sale of 4,106 shares at $30.35 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0002138368-26-000007 · filed 2026-08-17 · View filing →

SEC FORM 4
$93.39

Cue Biopharma, Inc. (CUE)

Sale of 3 shares at $31.13 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0002138368-26-000007 · filed 2026-08-17 · View filing →

SEC FORM 4
$147,451.37

Cue Biopharma, Inc. (CUE)

Sale of 5,423 shares at $27.19 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →

SEC FORM 4
$66,761.25

Cue Biopharma, Inc. (CUE)

Sale of 2,375 shares at $28.11 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →

SEC FORM 4
$308,360.80

Cue Biopharma, Inc. (CUE)

Sale of 10,460 shares at $29.48 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Cue Biopharma, Inc. (CUE)

Acquisition (code M) of 109,179 shares at $0 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →

SEC FORM 4
$923,732.75

Cue Biopharma, Inc. (CUE)

Sale of 34,225 shares at $26.99 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →

SEC FORM 4
$160,256.25

Cue Biopharma, Inc. (CUE)

Sale of 5,775 shares at $27.75 per share.

Reporting Person Lin Shao-Lee · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001725092-26-000013 · filed 2026-08-14 · View filing →